About this data
What it is
Capitol Hires lists lobbyists who say, in a filing under the Lobbying Disclosure Act, that they once held a government job: in a member of Congress’ office, on a congressional committee or in the executive branch. Each row names the public company that hired the lobbyist (directly or through a lobbying firm), the office they came from and the job they held there.
Who files it
The lobbying firm (or the company, for its own lobbyists) on each quarterly report (LD-2) and registration (LD-1) it files with the Senate and the House.
How current
New filings are posted every day. We read each one the day after it is posted.
Terms
Covered positionA covered position is a job in the federal government that a lobbyist held in the 20 years before the filing: in the office of a member of Congress, on a committee, or in the executive branch. The Lobbying Disclosure Act asks the lobbyist to name it.As writtenThe office, the member and the job title are shown as the registrant typed them. A short job title such as LD or CoS is not spelled out.Linked memberA member is linked to their page only when exactly one member of Congress fits the name, the chamber, the first name and the years given. Otherwise the name is shown as written, without a link.FilingsThe same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one.
Worth knowing
Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The text is free-form, so we read it by rules and some offices are missed or misread. Check the filing before relying on one row. A member is linked only on a unique match, and many are not: those are shown as written. Company matching is automatic and can miss a subsidiary. Information, not investment advice.

All of this comes from lobbying disclosure filings that the Senate and the House publish.

Latest Capitol Hires

Reset
Capitol Hires
The covered position the lobbyist says they held: an office of a member of Congress, a committee or an executive-branch body, as written in the filing. The member's name is a link only when exactly one member of Congress fits the name, chamber, first name and years given; otherwise it stays as written.The lobbying report (LDA form LD-2) that names this lobbyist and office, with a link to it. Report period is the quarter the report covers; Posted is the day it was filed or amended, which can be much later. The same lobbyist is named again on each quarterly report for the same client, so a row is shown once, from the newest report, with the number of filings that name them.
RARE
Ultragenyx Pharmaceutical Inc.
Sean BradyDOC
Executive branch
Dir Leg Affairs ( , Intl Trade Admin)Mehlman Consulting, Inc.
Report period 2026 Q3 ↗
Posted Oct 20, 2026
RARE
Ultragenyx Pharmaceutical Inc.
Sean BradyVern Buchanan
Member office · Republican-FL
CoS, Dep. CoS/ LD, SLA, LA, Staff Asst (Mehlman Consulting, Inc.
Report period 2026 Q3 ↗
Posted Oct 20, 2026
RARE
Ultragenyx Pharmaceutical Inc.
Sean BradyFred Upton
Member office · Republican-MI
Intern (Mehlman Consulting, Inc.
Report period 2026 Q3 ↗
Posted Oct 20, 2026
RARE
Ultragenyx Pharmaceutical Inc.
Sean BradyDaniel E. Lungren
Member office · Republican-CA
Intern (Mehlman Consulting, Inc.
Report period 2026 Q3 ↗
Posted Oct 20, 2026
RARE
Ultragenyx Pharmaceutical Inc.
Keenan Austin ReedA. Donald McEachin
Member office · Democrat-VA
Chief of StaffAlpine Group Partners, LLC
Report period 2026 Q3 ↗
Posted Oct 18, 2026 · in 3 filings
RARE
Ultragenyx Pharmaceutical Inc.
Keenan Austin ReedFrederica S. Wilson
Member office · Democrat-FL
Deputy Chief of StaffAlpine Group Partners, LLC
Report period 2026 Q3 ↗
Posted Oct 18, 2026 · in 3 filings
RARE
Ultragenyx Pharmaceutical Inc.
Shayne WoodsTim Scott
Member office · Republican-SC
Senior Legislative AssistantAlpine Group Partners, LLC
Report period 2026 Q3 ↗
Posted Oct 18, 2026 · in 3 filings
RARE
Ultragenyx Pharmaceutical Inc.
Shayne WoodsGus M. Bilirakis
Member office · Republican-FL
Senior Policy AdvisorAlpine Group Partners, LLC
Report period 2026 Q3 ↗
Posted Oct 18, 2026 · in 3 filings
RARE
Ultragenyx Pharmaceutical Inc.
Erin MendelsohnAnna G. Eshoo
Member office · Democrat-CA
LDAlpine Group Partners, LLC
Report period 2026 Q3 ↗
Posted Oct 18, 2026 · in 3 filings
RARE
Ultragenyx Pharmaceutical Inc.
Erin MendelsohnFDA
Executive branch
Congressional LiaisonAlpine Group Partners, LLC
Report period 2026 Q3 ↗
Posted Oct 18, 2026 · in 3 filings
RARE
Ultragenyx Pharmaceutical Inc.
Ashley GunnWhite House Office of Cabinet Affairs
Executive branch
Special Asst to the President, Senior DirectorMiller Strategies, LLC
Report period 2026 Q1 ↗
Posted Apr 20, 2026 · in 2 filings
RARE
Ultragenyx Pharmaceutical Inc.
Natalie McIntyreOffice of Legislative Affairs
Executive branch
Special Assistant to the PresidentMiller Strategies, LLC
Report period 2026 Q1 ↗
Posted Apr 20, 2026 · in 2 filings
RARE
Ultragenyx Pharmaceutical Inc.
Natalie McIntyreBill Hagerty
Member office · Republican-TN
Legislative DirectorMiller Strategies, LLC
Report period 2026 Q1 ↗
Posted Apr 20, 2026 · in 2 filings
RARE
Ultragenyx Pharmaceutical Inc.
Natalie McIntyreOMB
Executive branch
Deputy Associate Director, Legislative AffairsMiller Strategies, LLC
Report period 2026 Q1 ↗
Posted Apr 20, 2026 · in 2 filings
RARE
Ultragenyx Pharmaceutical Inc.
Natalie McIntyreONDCP
Executive branch
Senior Policy Advisor and White House LiaisonMiller Strategies, LLC
Report period 2026 Q1 ↗
Posted Apr 20, 2026 · in 2 filings
RARE
Ultragenyx Pharmaceutical Inc.
Natalie McIntyreMcConnell (Senate)
Member office · Senate
Legislative AssistantMiller Strategies, LLC
Report period 2026 Q1 ↗
Posted Apr 20, 2026 · in 2 filings
RARE
Ultragenyx Pharmaceutical Inc.
Barrett ThornhillMike Crapo
Member office · Republican-ID · 2003–2006
Legislative AssistantForbes-Tate
Report period 2026 Q1 ↗
Posted Apr 17, 2026
RARE
Ultragenyx Pharmaceutical Inc.
Earl FloodRobin L. Kelly
Member office · Democrat-IL
Dep. CoS, LD (Mehlman Consulting, Inc.
Report period 2025 Q4 ↗
Posted Jan 16, 2026
RARE
Ultragenyx Pharmaceutical Inc.
Earl FloodTerri A. Sewell
Member office · Democrat-AL
Health Pol Adv, Csl (Mehlman Consulting, Inc.
Report period 2025 Q4 ↗
Posted Jan 16, 2026
RARE
Ultragenyx Pharmaceutical Inc.
Earl FloodCedric L. Richmond
Member office · Democrat-LA
Csl (Mehlman Consulting, Inc.
Report period 2025 Q4 ↗
Posted Jan 16, 2026
RARE
Ultragenyx Pharmaceutical Inc.
Earl FloodClaire McCaskill
Member office · Democrat-MO
Pol Aide (Mehlman Consulting, Inc.
Report period 2025 Q4 ↗
Posted Jan 16, 2026
RARE
Ultragenyx Pharmaceutical Inc.
Joseph BrownShelley Moore Capito
Member office · Republican-WV
Prof Staff ( Comm Min/Ranking MemMehlman Consulting, Inc.
Report period 2025 Q3 ↗
Posted Oct 17, 2025
RARE
Ultragenyx Pharmaceutical Inc.
Joseph BrownBoozman (Senate)
Member office · Senate
Leg Asst (Mehlman Consulting, Inc.
Report period 2025 Q3 ↗
Posted Oct 17, 2025
RARE
Ultragenyx Pharmaceutical Inc.
Joseph BrownSenate Environment and Public Works
Committee
Maj Research Asst ( Comm MajMehlman Consulting, Inc.
Report period 2025 Q3 ↗
Posted Oct 17, 2025
RARE
Ultragenyx Pharmaceutical Inc.
Joseph BrownJames M. Inhofe
Member office · Republican-OK
Maj Research Asst ( Comm MajMehlman Consulting, Inc.
Report period 2025 Q3 ↗
Posted Oct 17, 2025
RARE
Ultragenyx Pharmaceutical Inc.
Joseph BrownJames B. Renacci
Member office · Republican-OH
Intern (Mehlman Consulting, Inc.
Report period 2025 Q3 ↗
Posted Oct 17, 2025
RARE
Ultragenyx Pharmaceutical Inc.
Jon AdameBlackburn (House)
Member office · House
Counsel (Mehlman Consulting, Inc.
Report period 2025 Q2 ↗
Posted Jul 21, 2025
RARE
Ultragenyx Pharmaceutical Inc.
Jon AdameHouse Energy and Commerce
Committee
Policy CoordinatorMehlman Consulting, Inc.
Report period 2025 Q2 ↗
Posted Jul 21, 2025
RARE
Ultragenyx Pharmaceutical Inc.
Jon AdameDomenici (Senate)
Member office · Senate
Intern (Mehlman Consulting, Inc.
Report period 2025 Q2 ↗
Posted Jul 21, 2025

The newest 29 of 29 matching. Narrow them with the filters above.

Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one. Updated Nov 15, 2026, 5:28 PM EST.